Activity Monitoring in Pulmonary Hypertension
Active, not recruiting · NCT04101630
Conditions: Pulmonary Hypertension
At a glance
- Research payments reported, 2025
- $170,000
- U.S. investigators named
- 2
- Sites paid
- 1
- Planned or actual enrollment
- 230
About the trial
- Sponsor
- Vanderbilt University Medical Center
- Tested
- Activity Monitoring (behavioral)
- Dates
- Started 2019-10-24; completion 2028-01
- Results posted
- Not yet
This is a prospective, longitudinal, observational study of free-living activity trackers and patient reported outcomes to test the hypothesis that daily activity will have stronger prognostic value than 6MWD in patients with pulmonary hypertension after 12 weeks.
From ClinicalTrials.gov, last updated 2026-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
United Therapeutics Corporation reported $170,000 in research payments for this study in 2025 (3 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Matthew D. Bacchetta, MD Cardiothoracic Surgery · Nashville, TN
- Caitlin T. Demarest, M.D. Cardiothoracic Surgery · Nashville, TN
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.